Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Interest & Investment Income (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Interest & Investment Income for 2 consecutive years, with $167311.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 446.5% to $167311.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $409094.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $166498.0 for FY2025, 24.35% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $167311.0 at Neuphoria Therapeutics, up from $141996.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $167311.0 in Q4 2025, with the low at $12741.0 in Q1 2025.